| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | WO2006090208A1 Process and methods for the preparation of gabapentin and its intermediates |
| 08/31/2006 | WO2006090153A1 Process for preparing protected amiidines |
| 08/31/2006 | US20060194868 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194795 Platelet ADP receptor inhibitors |
| 08/31/2006 | US20060194772 Triamide-substituted heterobicyclic compounds |
| 08/31/2006 | US20060194328 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 08/31/2006 | US20060193780 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2599301A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| 08/31/2006 | CA2598995A1 Dimeric iap inhibitors |
| 08/31/2006 | CA2598993A1 Tetrahydroindolone and tetrahydroindazolone derivatives |
| 08/31/2006 | CA2598816A1 Process and methods for the preparation of gabapentin and its intermediates |
| 08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | CA2598496A1 Process for preparing protected amiidines |
| 08/30/2006 | EP1695960A1 Near-infrared fluorescent contrast medium |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | CN1826352A Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 08/30/2006 | CN1826351A Novel method for the synthesis of perinidopril and the pharmaceutically acceptable salts thereof |
| 08/30/2006 | CN1826344A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use |
| 08/30/2006 | CN1826318A Stable modifications of tegaserod hydrogen maleate |
| 08/30/2006 | CN1826309A O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1272318C Colouring pigment of eye lense and stained eye lense therewith |
| 08/30/2006 | CN1272105C Catalysts comprising N-substituted cyclic imides and processes for preparing organic compounds with catalysts |
| 08/29/2006 | US7098345 Transamination of orndansetron preparing by Mannich reaction and isolation of product |
| 08/29/2006 | US7098307 Neo-tryptophan |
| 08/29/2006 | US7098237 administering type II sPLA2 inhibitor such as 2-[[3-(2-amino-2-oxoethyl)-2-ethyl-1-(1-naphthyl)methylene-1H-indene-4-yl]oxy]acetic acid |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098235 Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098233 5-halo-tryptamine derivatives used as ligands on the 5-HT6 and/or 5-HT7 serotonin receptors |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7097706 non-calcined clay composite includes clay, lime, blast furnace slag, alkaline chemical, and water in specified amounts, and has high compression strength due to an ionic coagulation reaction, a pozzolan reaction, and a latent hydraulic reaction |
| 08/29/2006 | CA2280905C Highly lipophilic camptothecin derivatives |
| 08/24/2006 | WO2006089053A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | WO2006087140A1 Novell processes for the preparation of a benzofuran |
| 08/24/2006 | WO2006025991A3 Isoindoline compounds and methods of making and using the same |
| 08/24/2006 | WO2006005063A3 Methods and compositions |
| 08/24/2006 | WO2006001958A3 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 08/24/2006 | US20060189813 Amidating a 2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid or ester with a 2-substituted propionyl chloride in the presence of a base; amination with ethyl 2-aminovaleraate, and hydrogenation; uses readily obtainable starting materials; 1-(2-substituted propionyl)hexahydroindole-2-carboxylates |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189677 Treatment of arrhythmia and the production of analgesia and local anesthesia by administering 1-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(3-hydroxy-1-pyrrolidinyl)cyclohexane or a salt |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189646 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060188927 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA |
| 08/24/2006 | CA2597616A1 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | CA2596668A1 Novel processes for the preparation of a benzofuran |
| 08/23/2006 | EP1693366A1 Selective 5-HT 6 receptor ligands |
| 08/23/2006 | EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 08/23/2006 | EP1692229A1 Polymeric dispersant |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692106A1 A novel synthesis of 2-azabicyclic-3-carboxylic acids, useful as important drug intermediates |
| 08/23/2006 | EP1692105A1 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives |
| 08/23/2006 | EP1692090A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 08/23/2006 | EP1691804A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 08/23/2006 | EP1534271B1 Antitumor compound and therapeutic uses thereof |
| 08/23/2006 | EP1476426B1 Hydroxylated indirubin derivatives |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823038A Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 08/23/2006 | CN1821247A Camptothecine derivatives and their use |
| 08/23/2006 | CN1821245A Camptothecine derivative and its preparation |
| 08/23/2006 | CN1821225A Synthetic method of fire-retardant N,N'-ethylene bis-tetrabromo phthalimide and screw thrust tubular reactor |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/23/2006 | CN1271073C Crystalline anti-cholinergic tiotropium crystal |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/23/2006 | CN1271051C Aza aromatic ring substitutional four branched functional molecule material and preparation method |
| 08/22/2006 | US7094908 Chemical intermediates for antibiotics |
| 08/22/2006 | US7094869 Animal growth regulators |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094800 pyrrolizinones, e.g., (3S,6R,7aS)-6-amino-5-oxo-hexahydro-pyrrolizine-3-carbonitrile trifluoroacetate, used for reducing blood sugar, treating type 2 diabetes, and treating insulin resistance |
| 08/22/2006 | US7094799 A single, thermodynamical stable crystal structure, is crystallized from a cooled and agitated solvent solution, analgesic drug for reducing pain |
| 08/22/2006 | US7094798 pyrrolocarbazole derivatives, e.g., 2-(4-(2,6-Dichlorophenyl)-9-hydroxy-1,3-dioxo-2,3-dihydropyrrolo[3,4-c]carbazol-6 (1H)-yl)ethyl methanesulfonate |
| 08/22/2006 | US7094796 Coupling product between tryptamine and an alpha-amino acid, process for its preparation as well as its application in the neurocosmetic field |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | CA2270301C Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for their preparation |
| 08/22/2006 | CA2239568C Improved metal-ligand complex catalyzed processes |
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2006086657A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | WO2006085332A1 Improved process for preparation of highly pure trandolapril |